For the first time in history, the United States will host a dedicated conference focusing exclusively on the intricate field of Chagas disease research. This landmark event marks not only a significant milestone for the scientific community but also symbolizes a pivotal shift in the recognition of Chagas disease within the borders of the U.S. The inaugural U.S. Chagas Disease Meeting, scheduled from March 26 to 27, will take place at Tulane University in New Orleans. This gathering highlights the growing urgency to raise awareness, enhance research initiatives, and improve clinical management strategies for a disease that, until now, was largely considered a problem confined to Latin America. In fact, emerging research from the prior year strongly suggests that Chagas disease should be classified as endemic within the United States, a perspective that upends previous assumptions about its geographical limitations.
Chagas disease, scientifically known as American trypanosomiasis, is caused by the protozoan parasite Trypanosoma cruzi. The parasite is primarily transmitted by triatomine insects, colloquially referred to as “kissing bugs” due to their tendency to bite human facial areas during nocturnal hours. While the disease has been well-documented across 21 countries in the Americas, its presence and prevalence in the U.S. have been historically underreported or overlooked. This disease is categorized by the Pan American Health Organization as a neglected tropical disease. Such classification points to the chronic underdiagnosis and limited public health prioritization it suffers from, despite its potentially severe health consequences.
The clinical implications of Chagas disease are profound and multifaceted. The parasite initially causes an acute infection that may be asymptomatic or present with mild symptoms. However, without timely therapeutic intervention, the infection frequently progresses to a chronic phase characterized by cardiac complications such as arrhythmias, cardiomyopathy, and eventually heart failure. These cardiovascular manifestations pose a significant risk of morbidity and mortality. Moreover, an overlooked mode of transmission is congenital, whereby infected mothers can pass the parasite transplacentally to their offspring, underscoring the urgent need for prenatal screening and intervention protocols.
Recognition of Chagas disease as endemic to the United States represents a critical advancement in public health strategy. By acknowledging domestic transmission cycles, health authorities can expand surveillance systems, increase diagnostic testing availability, and allocate resources towards research and community education. Such efforts are necessary to dismantle the longstanding misconception that this tropical parasitic disease is exclusively a problem for Latin American countries, a misconception that has historically hindered adequate response within U.S. borders.
Dr. Claudia Patricia Herrera, an assistant professor at Tulane University’s Celia Scott Weatherhead School of Public Health and Tropical Medicine, emphasizes the transformative potential of this conference. Herrera articulates that the event’s goal is to establish a robust, interconnected network of experts, clinicians, and public health professionals dedicated to advancing research and improving patient outcomes. This collaborative approach is expected to accelerate the development of innovative diagnostics, refine treatment protocols, and enhance educational outreach tailored specifically for affected populations within the United States.
The conference is also reflective of an increasing recognition within the biomedical community of Chagas disease as a public health issue of growing relevance in the U.S. According to estimates from the Centers for Disease Control and Prevention (CDC), approximately 300,000 Americans may currently carry the infection. This underscores the critical need to integrate Chagas disease considerations into broader healthcare frameworks, including cardiology, infectious disease, and prenatal care specialties.
Over the course of the two-day meeting in New Orleans, experts from multiple disciplines will present the latest advances in diagnostic technologies, screening methodologies, and patient management strategies. Of particular interest is the development of serological tests with increased sensitivity and specificity that can effectively identify asymptomatic cases. Enhanced diagnostic capacity will enable earlier intervention, thereby mitigating long-term cardiac damage and improving survival rates.
Research sessions will also delve into vector ecology and control measures, tracing the life cycle and behavior of triatomine bugs in U.S. environments. Understanding local vector dynamics is essential to interrupting transmission cycles and reducing disease incidence. Additionally, discussions will address the socioeconomic and cultural barriers that contribute to underdiagnosis and treatment disparities in immigrant and marginalized communities disproportionately affected by Chagas disease.
Importantly, the meeting will foster dialogue on the implementation of public health policies geared toward nationwide screening programs, particularly targeting congenital transmission and blood transfusion safety. Current guidelines fall short in several states, and experts advocate for the harmonization of protocols to ensure comprehensive protection against this insidious infection.
This conference not only symbolizes a turning point in the epidemiology of Chagas disease but also represents an urgent call to action. Heightened awareness, coupled with new research insights, offers hope for more effective disease control within the United States. The advancement of collaborative research networks and patient care initiatives promises to transform the landscape of Chagas disease management, protecting vulnerable populations and ultimately reducing the burden of this neglected tropical disease on the American health system.
For media inquiries or further information, interested parties may contact Andrew Yawn, Assistant Director of Media Relations at Tulane University, via email at ayawn@tulane.edu.
Subject of Research: Chagas disease, its epidemiology, clinical impact, and emerging recognition as an endemic infectious disease in the United States
Article Title: U.S. to Host Inaugural Chagas Disease Meeting: Shifting Paradigms in Recognition and Research
News Publication Date: Not specified in the source content
Web References:
- https://www.uschagasmeeting26.org/
- https://www.cnn.com/2025/09/16/health/kissing-bug-chagas-endemic-us
Keywords: Chagas disease, Trypanosoma cruzi, kissing bugs, neglected tropical diseases, endemic disease, parasitic diseases, infectious diseases, public health, cardiac complications, vector control, congenital transmission, diagnostic testing
